Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.98
Surgery Partners, Inc. terminated Existing Indentures (2027 Notes Indenture and 2025 Notes Indenture) with Wilmington Trust, National Association valued at Satisfaction and discharge of 10.000% Senior Notes due 2027 and 6.750% Senior Notes due 2025 (effective 2024-04-10).
- Action
- termination
- Agreement
- notes offering
- Counterparty
- Wilmington Trust, National Association
- Value
- Satisfaction and discharge of 10.000% Senior Notes due 2027 and 6.750% Senior Notes due 2025
- Effective
- 2024-04-10
Exact text from the filing
In connection with the issuance of the Notes, on April 10, 2024, the Issuer effected a satisfaction and discharge of those certain Indentures, dated as of April 11, 2019 (the “2027 Notes Indenture”), among the Issuer, the guarantors party thereto from time to time and the Trustee, governing the Issuer’s 10.000% Senior Notes due 2027 (the “2027 Notes”) and that certain Indenture, dated as of June 30, 2017 (the “2025 Notes Indenture” and together with the 2027 Notes Indenture, the “Existing Indentures”), among the Issuer, the guarantors party thereto from time to time and the Trustee, governing the Issuer’s 6.750% Senior Notes due 2025 (the “2025 Notes” and together with the 2027 Notes, the “Existing Notes”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
Surgery Partners, Inc. entered into Indenture dated April 10, 2024 with Wilmington Trust, National Association valued at $800,000,000 7.250% senior unsecured notes due 2032 (effective 2024-04-10).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- Wilmington Trust, National Association
- Value
- $800,000,000 7.250% senior unsecured notes due 2032
- Effective
- 2024-04-10
Exact text from the filing
On April 10, 2024, Surgery Center Holdings, Inc. (the “Issuer”), a wholly owned subsidiary of Surgery Partners, Inc. (the “Registrant”), completed the issuance and sale of $800.0 million in gross proceeds of the Issuer’s 7.250% senior unsecured notes due 2032 (the “Notes”).
View on SEC.gov